Dover Corporation: Q3 2022 Form 10-Q Summary
Business context and reporting period
Dover is a diversified global manufacturer and solutions provider operating through five segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions, and Climate & Sustainability Technologies. This unaudited Form 10-Q covers the three and nine months ended September 30, 2022, compared with the corresponding 2021 periods.
Key financial metrics
| Metric | Q3 2022 | Q3 2021 | Change |
|---|---|---|---|
| Revenue | $2.158 billion | $2.018 billion | +6.9% |
| Gross profit | $772.8 million | $754.6 million | +2.4% |
| Gross margin | 35.8% | 37.4% | -160 bps |
| Operating earnings | $370.4 million | $342.0 million | +8.3% |
| Net earnings | $286.0 million | $263.8 million | +8.4% |
| Diluted EPS | $2.00 | $1.81 | +10.5% |
| Effective tax rate | 19.0% | 19.5% | -50 bps |
For the nine months ended September 30, 2022, revenue was $6.369 billion, up 7.6%; net earnings were $801.8 million, up 5.4%; and diluted EPS was $5.55, up 5.9%. Gross margin declined to 36.1% from 38.0%, while operating earnings increased 2.8% to $1.027 billion. The nine-month effective tax rate was 16.8% versus 19.0% in 2021, including a $22.6 million benefit related to the Tax Cuts and Jobs Act and favorable audit resolutions.
Cash flow, debt and liquidity
- Nine-month operating cash flow was $467.1 million, down from $788.6 million; free cash flow was $301.0 million versus $667.4 million.
- Cash flow was pressured by higher receivables and inventories, compensation payments, tax payments, and increased capital expenditures. Inventory increased to $1.408 billion from $1.191 billion at year-end 2021.
- Capital expenditures were $166.0 million through September 30, 2022; management expected full-year capital expenditures of approximately $200 million to $220 million.
- Cash and cash equivalents were $306.0 million, including $250.8 million held outside the United States.
- Total debt was $3.632 billion, consisting of $788.9 million of short-term borrowings and $2.843 billion of long-term debt, compared with total debt of $3.124 billion at December 31, 2021.
- Net debt to net capitalization increased to 45.4% from 39.5%, primarily because commercial paper funded the accelerated share repurchase and the Malema acquisition.
- Dover had no borrowings under its $1.0 billion revolving credit facility, which expires October 4, 2024. The company reported a 17.5-to-1 interest coverage ratio versus a 3.0-to-1 covenant requirement and stated that it was in compliance with its debt covenants.
Material changes versus the prior comparable period
- Revenue growth reflected 9.0% organic growth and 4.4% acquisition-related growth, partly offset by 4.8% unfavorable foreign currency translation and 1.7% disposition-related decline.
- Pricing contributed approximately 7.6% to third-quarter revenue and helped offset higher material, energy, labor, freight and logistics costs, but gross margins declined.
- Engineered Products revenue increased 15.3% and segment earnings increased 33.8%; Climate & Sustainability Technologies revenue increased 7.7% and segment earnings increased 51.2%.
- Clean Energy & Fueling revenue increased 13.0%, primarily from acquisitions, while organic revenue declined 0.5% and segment margin decreased modestly.
- Imaging & Identification revenue declined 3.5% because of foreign exchange, despite 4.9% organic growth; segment earnings increased 5.4%.
- Pumps & Process Solutions revenue declined 1.1% and segment earnings declined 14.4%, primarily due to lower demand for COVID-19 vaccine-related single-use components, inflation and foreign exchange.
- Third-quarter bookings declined 10.1% to approximately $2.1 billion, while backlog increased to $3.2 billion from $2.8 billion.
- Dover acquired Malema and AMN for aggregate consideration of $229.3 million during the first nine months. Malema accounted for $220.8 million and expanded the biopharmaceutical flow measurement and control offering.
- The company repurchased $585.0 million of common stock during the first nine months, including a $500.0 million accelerated share repurchase funded with commercial paper. The ASR was scheduled for completion in the fourth quarter, with the final number of shares dependent on the applicable volume-weighted average price.
Guidance, outlook, risks and unusual items
- No full-year revenue or earnings guidance is clearly provided in the filing. Management expected full-year capital expenditures of approximately $200 million to $220 million.
- Management expected continued organic revenue growth in Engineered Products and Climate & Sustainability Technologies, modest improvement in Clean Energy & Fueling organic growth, and continued positive demand in Imaging & Identification.
- Management expected COVID-19 vaccine-related product sales in Pumps & Process Solutions to continue declining through 2022 and into early 2023.
- Supply chain constraints, labor shortages, input-cost inflation, energy and freight costs, foreign currency movements, weakening macroeconomic conditions and customer demand changes remain principal risks.
- Restructuring and other costs were $8.6 million in the quarter and $27.1 million year to date, primarily related to headcount reductions, facility consolidation, organizational simplification and certain Latin America exit activities. Additional programs could be implemented.
- Foreign currency translation produced a $210.6 million year-to-date after-tax reduction in other comprehensive earnings, substantially affecting stockholders’ equity.
- Outstanding letters of credit, surety bonds and performance guarantees totaled approximately $168 million. Management stated that material legal and environmental liabilities were not present at September 30, 2022.
- Management identified COVID-19 developments, supply-chain disruption, inflation, tariffs and trade policy, acquisitions and integration, interest rates, foreign exchange, cybersecurity, product liability, intellectual property and litigation as risks that could cause actual results to differ materially from expectations.
Facts investors should verify
- Whether pricing continues to offset inflation without further erosion in gross and segment margins.
- The pace of bookings relative to revenue, particularly the effect of declining bookings in Clean Energy & Fueling, Pumps & Process Solutions and Climate & Sustainability Technologies.
- The final share count and settlement economics of the $500 million accelerated share repurchase.
- Commercial paper refinancing needs, interest-rate exposure and progress toward reducing leverage.
- Integration performance and contingent consideration associated with Malema and other acquisitions.
- The sustainability of operating cash flow after elevated working-capital investment, capital expenditures and tax payments.